DENVER, Feb. 27, 2006 (PRIMEZONE) -- Chelsea Management Group Inc. (Other OTC:CLMP) has reached a marketing and distribution agreement with Progressive Health Nutraceuticals of Boise Idaho. The agreement allows Chelsea to market, distribute and sell Exomine and Exomine RH through various distribution outlets and through our website at www.wellnessbegins.com.
Exomine and Exomine RH are natural products developed to reduce pain caused by arthritis. Exomine is formulated to reduce joint pain and reduce pain caused by Osteoarthritis. In one study over a three month period, subjects who took the same ingredients that are in Exomine experienced a gradual reduction in joint pain and tenderness while improving flexibility and range of motion.
Exomine RH is a unique blend of ingredients that is specifically formulated to support those suffering from Rheumatoid Arthritis. A recent report indicates that over 2.1 million (mostly women) are affected with rheumatoid arthritis. While rheumatoid arthritis usually affects the mid-aged population, RA can often occur in your twenties and thirties.
"These two new products are an addition to our Wellness Center division. We will keep on expanding the product lines as they come available." said Peter Johansen, CEO of Chelsea. Our cyber outlet is located at www.wellnessbegins.com.
Chelsea Management Group is a start-up and early-stage venture capital firm focused on the health and life sciences industry. Formed in 2001, Chelsea searches for the winners of tomorrow -- entrepreneurs whose ideas and talents qualify them to pursue large market opportunities successfully. We seek opportunities across a broad spectrum, including biotechnology and pharmaceuticals, medical devices, services and healthcare/life sciences information technology. On a selective basis, we also consider later-stage health and life sciences investments where we can uniquely apply Chelsea's industry and capital markets experience.
Safe Harbor Statement
All statements other than statements of historical fact included in this press release are "forward-looking statements." The forward-looking statements, including statements about the company's future expectations, including future revenues and earnings, and all other forward-looking statements (i.e. future operational results and sales) are subject to assumptions and beliefs based on current information known to the company and factors that are subject to uncertainties, risk and other influences, which are outside the company's control and may yield results differing materially from those anticipated.